Scopa James Paul
SEC insider (Form 3/4/5 filer). CIK 0001356950. Director at Aligos Therapeutics, Inc. (ALGS) and 1 other issuer. 12 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Scopa James Paul has filed insider reports for
- Aligos Therapeutics, Inc. (ALGS): Director
- Adverum Biotechnologies, Inc. (ADVM): Director
Scopa James Paul
CIK: 0001356950
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jun 25, 2026ALGS
Aligos Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
5.9K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
4.7K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
4.5K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
3K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
4K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
4K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
Tender OfferDirect10.3K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
10.5K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
10.5K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2026 |  ALGS Aligos Therapeutics, Inc. | Award Stock Option (Right to Buy) | 5,860 | - | - | Direct |
| Dec 9, 2025 |  ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 4,666 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 4,500 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 3,000 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 4,000 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 4,000 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Tender Offer | 10,333 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 10,520 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 10,450 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 4,000 | - | - | Direct |
1-10 of 12 transactions